Adeno-associated Virus Vectors (AAVs) Downstream Processing Market

Global Adeno-associated Virus Vectors (AAVs) Downstream Processing Market Size, Trends & Analysis - Forecasts to 2028 By Product (Chromatography Systems [Affinity Chromatography, Ion Exchange Chromatography, Size Exclusion Chromatography, Others], Filtration Solutions [Depth Filtration Products, Tangential Flow Filtration Systems, Others], Centrifuges, Others), By Product Type (Single-Use, Multi-Use), By Application (Cell & Gene Therapy Development, Vaccine Development, Others), By Workflow (Purification, Polishing, Fill Finish), By End-User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on February 15 2024 with the latest and most recent market numbers

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market Size

The global adeno-associated virus vectors (AAVs) downstream processing market is projected to grow from USD 27.4 billion in 2022 to USD 48.1 billion by 2028 at a CAGR of 15.3% from 2023 to 2028.

Due to substantial growth and interest in various fields of research in the medical sector, the global market for adeno-associated virus vectors (AAVs) downstream processing market has seen an increased market share. Due to the pandemic, the growth is accelerated for downstream processing techniques as it is used for the development of COVID-19 vaccines.

Rentschler Biopharma and Vetter announced the March 2022 launch of Xpert Alliance, a collaborative representation of their strategic relationship. The visualization aims to bring to life this ongoing collaboration and highlight its successful operation in providing effective solutions to customers' evolving and growing demands in the field of difficult biopharmaceuticals.

Adeno-associated virus vectors (AAVs) downstream processing market offers space for the modification of cells, and standardization of cells which can be utilized for cancer treatments, diabetes trials, and cardiovascular diseases. Many stem cell treatments are costly, but due to their widespread use in clinical research and disease treatment, the global adeno-associated virus vectors (AAVs) downstream processing market is expected to grow during the forecast period.

The major players in the market are targeting to achieve more ventures with fellow market companies and increase research activities for developing further treatments for chronic diseases. For instance, in April 2022, Bayer issued a statement saying they are looking for local and international collaborations for advancing its research and technologies in synthetic biology and vaccine production.

global adeno-associated virus vectors (aavs) downstream processing market

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market: By End-Use

The pharmaceutical and biopharmaceutical companies segment is expected to witness the largest share in the global adeno-associated virus vectors (AAVs) downstream processing market during the forecast period of 2023-2028. Many companies do complex testing daily for chronic diseases and they do have advanced research facilities. With many diseases increasing and with more awareness for research of cures and drugs, the pharmaceutical and biopharmaceutical companies segment is expected to witness the largest share.

The research institutes segment is expected to grow the fastest during 2023-2028. Research institutes conduct clinical research that bridges the current gaps and identifies treatment plans for existing stem cell projects. This increased awareness in research, additional funding, and government initiatives save time and cost of production with efficiency and consistency.

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market: By Application

The cell & gene therapy development segment is expected to witness the largest share in the global adeno-associated virus vectors (AAVs) downstream processing market during the forecast period of 2023-2028. Cell therapy can help people with cardiovascular diseases by assisting blood vessels and a variety of cell functioning factors. Healthy tissue also promotes collagen regeneration and promotes healthy skin and hair. The rate of recovery following cell therapy is much faster, which drives the market during the forecast period. Gene therapy aids in the treatment of genetic disorders and cancer patients. Because of ongoing technological advancements, it also has a long-lasting effect, which can aid in disease management by improving quality of life. Pfizer, for example, has been introducing vector designs and developing labs for gene mutation and therapy since the FDA approved gene therapy, and the research is expanding at a rapid pace.

The vaccine development segment is expected to grow the fastest during 2023-2028. Many companies have strategically boosted their research and development, especially since the pandemic. This has helped in boosting the market significantly.

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market: By Product

The chromatography systems segment is expected to witness the largest share in the global adeno-associated virus vectors (AAVs) downstream processing market during the forecast period of 2023-2028. Continuous research and development activities to improve the efficiency and speed of chromatography systems are expected to drive segment growth. Thermo Fisher Scientific introduced the HyPeak chromatography system in April 2021; it is the company's only single-use chromatography system for bioprocessing, with important functions in therapeutic protein and vaccine development. An increase in chromatography system deals and developments also aids segment growth. Sartorius Stedim Biotech, for example, announced in January 2021 that it would acquire Novasep's chromatography equipment business.

The filtration solutions segment is expected to grow the fastest during 2023-2028.  The increased utility of filters for viral inactivation is the primary factor driving the downstream processing market.

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market: By Workflow

The purification segment is expected to witness the largest share in the global adeno-associated virus vectors (AAVs) downstream processing market during the forecast period of 2023-2028. This high growth is due to the demand for highly pure biopharmaceutical products as per the regulatory standards that help in enhancing the purity and quality of products.

The polishing segment is expected to witness the fastest share in the global adeno-associated virus vectors (AAVs) downstream processing market. Product polishing refers to the final processing steps that result in the product being packaged in a stable, transportable, and convenient form.

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market: By Product Type

The single-use segment is expected to witness the largest share in the global adeno-associated virus vectors (AAVs) downstream processing market during the forecast period of 2023-2028. Single-use product type provides filtration systems, buffer preparations, sampling, and dispensing systems.

The multi-use product type segment is expected to witness the fastest share during the forecast period. Multi-use processing products have high demand in chromatography products thus boosting the market for adeno-associated virus vectors (AAVs) downstream processing market.

asia pacific adeno-associated virus vectors (aavs) downstream processing market

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market: By Region

The North America segment is expected to witness the largest share in the global adeno-associated virus vectors (AAVs) downstream processing market during the forecast period of 2023-2028. Due to an increase in research in the healthcare segment, the North America segment will dominate the global Adeno-associated virus vectors (AAVs) Downstream Processing Market. This is also due to increased government support for bioprocess technologies, rising medical expenditures, and developed healthcare infrastructure. Furthermore, the region has seen significant collaborative activities with healthcare behemoths that are heavily investing in biopharmaceutical and vaccine R&D. Furthermore, key market players are expanding their presence in this region.

An increase in the standard of living, and new technologies in the medical sector are a few reasons which drive the market in the United States. As one of the most developed nations in the world, the United States is a hub for complex medical treatments for many people around the world.  The adeno-associated virus vectors (AAVs) downstream processing industry in the United States has been substantially strong for a few years due to the increasing demand for consumers in the healthcare domain, and it is estimated to grow further during the forecast period.

Asia-Pacific is expected to grow the fastest during 2023-2028. The Asia-Pacific region has been developing a huge infrastructure for the healthcare sector and many medical advancements via research. Furthermore, it has been rising technology and other advancements in the field of technical innovation. This boosts the global adeno-associated virus vectors (AAVs) downstream processing market. The presence of a large population base drives the need for advanced medical facilities, and players are eager to implement rapid analytical methods to support in-process designing and bioprocessing.

This competitive landscape helps in the growth rate of the global Adeno-associated virus vectors (AAVs) Downstream Processing Market. Furthermore, renowned companies like Merck KGaA, Thermo Fisher Scientific, and 3M Purification are expanding their business in Europe.

Global Adeno-associated virus vectors (AAVs) Downstream Processing Market Share and Competitor Analysis

Sartorius, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group Ltd, ChromaTan Inc., Repligen Corporation, 3M Purification, Meissner Filtration Products, Inc., and DrM, Dr. Mueller AG, are key players in the Adeno-associated virus vectors (AAVs) downstream processing market.

Please note: This is not an exhaustive list of companies profiled in the report.

The global adeno-associated virus vectors (AAVs) downstream processing market has observed several strategic alliances between company profiles to launch new products with added functionalities and maintain revenue share & profitability. Organic and inorganic growth strategies adopted by small players have been the highlight of this market.

Chapter 1   Research Methodology

1.1    Research Assumptions

1.2    Research Methodology

1.2.1    Estimates and Forecast Timeline

1.3    Information Procurement

1.3.1    Purchased Database

1.3.2    GME’s Internal Database

1.3.3    Primary Research

1.3.4    Secondary Sources & Third-Party Perspectives

            1.3.4.1    Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website

           1.3.4.2 Secondary Data Sources: World Health Organization

1.4    Information or Data Analysis

1.4.1    Data Analysis Models

1.5    Market Application & Data Visualization

1.6    Data Validation & Publishing

1.7   Market Model

1.7.1    Model Details

              1.7.1.1 Top-Down Approach

               1.7.1.2 Bottom-Up Approach

1.8    Market Segmentation & Scope

1.9    Market Definition

Chapter 2   Executive Summary

2.1.    Global Market Outlook

2.2     Product Outlook

2.3     Product Type Outlook

2.4     Application Outlook

2.5     Workflow Outlook

2.6     End-User Outlook

2.7     Regional Outlook

Chapter 3   Global Adeno-associated virus vectors (AAVs) downstream processing Market Trend Analysis

3.1. Market Introduction

3.2 Penetration & Growth Prospect Mapping

3.3 Impact of COVID-19 on the Adeno-associated virus vectors (AAVs) downstream processing Market

3.4 Metric Data on Healthcare Industry

3.5 Market Dynamic

3.5.1 Market Driver Analysis

3.5.2 Market Restraint Analysis

3.5.3 Industry Challenges

3.5.4 Industry Opportunities

3.6    Porter’s Five Analysis

3.6.1 Threat of New Entrants

3.6.2 Threat of New Substitutes

3.6.3 Bargaining Power of Buyers/Suppliers

3.6.4 Intensity of Competitive Rivalry

3.7 Market Entry Strategies

Chapter 4   Adeno-associated virus vectors (AAVs) downstream processing Market: Product Trend Analysis

4.1   Product: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

4.2     Chromatography

4.2.1    Market Estimates & Forecast Analysis of Chromatography Segment, By Region, 2022-2028 (USD Billion)

4.3   Filtration Solutions

4.3.1    Market Estimates & Forecast Analysis of Filtration Solutions Markets Segment, By Region, 2022-2028 (USD Billion)

Chapter 5   Adeno-associated virus vectors (AAVs) downstream processing Market: Workflow Trend Analysis

5.1   Workflow: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

5.2     Purification

5.2.1    Market Estimates & Forecast Analysis of Purification Segment, By Region, 2022-2028 (USD Billion)

5.2     Polishing

5.2.1    Market Estimates & Forecast Analysis of Polishing Segment, By Region, 2022-2028 (USD Billion)

5.2     Fill Finish

5.2.1    Market Estimates & Forecast Analysis of Fill Finish Segment, By Region, 2022-2028 (USD Billion)

Chapter 6   Adeno-associated virus vectors (AAVs) downstream processing Market: Product Type Trend Analysis

6.1    Product Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

6.2    Single-use

6.2.1    Market Estimates & Forecast Analysis of Single-use Segment, By Region, 2022-2028 (USD Billion)

6.3     Multi-use

6.3.1    Market Estimates & Forecast Analysis of Multi-use Segment, By Region, 2022-2028 (USD Billion)

Chapter 7   Adeno-associated virus vectors (AAVs) downstream processing Market: Application Trend Analysis

7.1    Application: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

7.2    Cell & Gene Therapy Development

7.2.1    Market Estimates & Forecast Analysis of Cell & Gene Therapy Development Segment, By Region, 2022-2028 (USD Billion)

7.3    Vaccine Development

7.3.1    Market Estimates & Forecast Analysis of Governance, Vaccine Development Segment, By Region, 2022-2028 (USD Billion)

Chapter 8   Adeno-associated virus vectors (AAVs) downstream processing Market: End-User Trend Analysis

8.1   End-User: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

8.2    Pharmaceutical and Biopharmaceutical Companies         

8.2.1    Market Estimates & Forecast Analysis of Pharmaceutical and Biopharmaceutical Companies Segment, By Region, 2022-2028 (USD Billion)

8.3    Research Institutes

8.3.1    Market Estimates & Forecast Analysis of Research Institutes Segment, By Region, 2022-2028 (USD Billion)

Chapter 9   Adeno-associated virus vectors (AAVs) downstream processing Market, By Region

9.1    Regional Outlook

9.2    North America

9.2.1    Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)

9.2.2    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.2.3    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.2.4    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.2.5    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.2.5    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.2.6    U.S.

9.2.6.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.2.6.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.2.6.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.2.6.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.2.6.5    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.2.7    Canada

9.2.7.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.2.7.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.2.7.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.2.7.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.2.6.5    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.2.8    Mexico

9.2.9.1    Market Estimates & Forecast Analysis, By Product, 2022-2028 (USD Billion)

9.2.9.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028 (USD Billion)

9.2.9.3    Market Estimates & Forecast Analysis, By Application, 2022-2028 (USD Billion)

9.2.9.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.2.6.5    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3    Europe

9.3.1    Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)

9.3.2    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.3    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.4    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.5    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.5    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.6    Germany

9.3.6.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.6.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.6.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.7    UK

9.3.7.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.7.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.7.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.7.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.8    France

9.3.9.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.9.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.9.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.9.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.9    Russia

9.3.9.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.9.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.9.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.9.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.10    Italy

9.3.11.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.11.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.11.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.11.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.11    Spain

9.3.11.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.11.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.11.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.11.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.12    Netherlands

9.3.12.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.3.12.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.3.12.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.3.12.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.3.13    Rest of Europe

9.3.13.1    Market Estimates & Forecast Analysis, By Product, 2022-2028 (USD Billion)

9.3.13.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028 (USD Billion)

9.3.13.3    Market Estimates & Forecast Analysis, By Application, 2022-2028 (USD Billion)

9.3.13.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4    Asia Pacific

9.4.1    Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)

9.4.2    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.3    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.4    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.5    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.4.6    China

9.4.6.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.6.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.6.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.6.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.7    India

9.4.7.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.7.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.7.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.7.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.8    Japan

9.4.9.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.9.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.9.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.9.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.9    Australia

9.4.9.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.9.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.9.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.9.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.10    South Korea

9.4.11.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.11.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.11.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.11.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.11    Thailand

9.4.11.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.11.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.11.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.11.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.12    Indonesia

9.4.12.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.12.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.12.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.12.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.13    Malaysia

9.4.13.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.13.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.13.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.13.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.14    Singapore

9.4.14.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.14.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.14.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.14.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.15    Vietnam

9.4.15.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.4.15.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.4.15.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.4.15.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.4.11    Rest of Asia Pacific

9.4.11.1    Market Estimates & Forecast Analysis, By Product, 2022-2028 (USD Billion)

9.4.11.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028 (USD Billion)

9.4.11.3    Market Estimates & Forecast Analysis, By Application, 2022-2028 (USD Billion)

9.4.11.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.5    Central & South America

9.5.1    Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)

9.5.2    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.5.3    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.5.4   Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.5.5   Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.5.6    Brazil

9.5.6.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.5.6.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.5.6.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.5.6.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.5.7    Rest of Central & South America

9.5.7.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.5.7.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.5.7.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.5.7.4    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.6    Middle East & Africa

9.6.1    Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)

9.6.2    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.6.3    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.6.4    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.6.5    Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.6.6    Saudi Arabia

9.6.6.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.6.6.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.6.6.3   Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.6.6.4   Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.6.7    United Arab Emirates

9.6.7.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.6.7.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.6.7.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.6.7.4   Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.6.8    South Africa

9.6.9.1    Market Estimates & Forecast Analysis, By Product, 2022-2028(USD Billion)

9.6.9.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028(USD Billion)

9.6.9.3    Market Estimates & Forecast Analysis, By Application, 2022-2028(USD Billion)

9.6.9.4   Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

9.6.9   Rest of Middle East & Africa

9.6.9.1    Market Estimates & Forecast Analysis, By Product, 2022-2028 (USD Billion)

9.6.9.2    Market Estimates & Forecast Analysis, By Product Type, 2022-2028 (USD Billion)

9.6.9.3    Market Estimates & Forecast Analysis, By Application, 2022-2028 (USD Billion)

9.6.9.4   Market Estimates & Forecast Analysis, By End-User, 2022-2028(USD Billion)

9.3.6.4    Market Estimates & Forecast Analysis, By Workflows, 2022-2028(USD Billion)

Chapter 10   Competitive Analysis

10.1    Key Global Workflows, Recent Developments & their Impact on the Industry

10.2    Four Quadrant Competitor Positioning Matrix

10.2.1    Key Innovators

10.2.2    Market Leaders

10.2.3    Emerging Workflows

10.2.4    Market Challengers

10.3    Vendor Landscape Analysis

10.3.1 List Of Key Technology Supplier

10.3.2 List Of Raw Material/Technology Distributors

10.3.3 Region-Wise Bioprocessing Technology Distributors

10.4    Manufacturer’s Landscape Analysis

10.4.1 Distribution By Location Of Manufacturing Facility

10.4.2 Distribution By Scale Of Production

10.4.3 Distribution By Location Of Manufacturing Facility, Type Of Organization, And Purpose Of Production

10.5 Key Initiatives & Strategic Alliances Analysis

10.5.1 Merger & Acquisition Deals

10.5.2 Collaborations & Partnerships

10.5.3 Business Expansion

10.5.4 Technology Collaborations

10.6    Company Market Share Analysis, 2022

Chapter 11   Company Profile Analysis

11.1    Competitive Analysis, 2022

11.2    Sartorius

11.2.1    Company Overview

11.2.2    Financial Analysis

11.2.3    Strategic Positioning

11.2.4    Product Portfolio

11.3    Merck KGaA.

11.3.1    Company Overview

11.3.2    Financial Analysis

11.3.3    Strategic Positioning

11.3.4    Product Portfolio

11.4     Thermo Fisher Scientific Inc.

11.4.1    Company Overview

11.4.2    Financial Analysis

11.4.3    Strategic Positioning

11.4.4    Product Portfolio

11.5     Danaher Corporation

11.5.1    Company Overview

11.5.2    Financial Analysis

11.5.3    Strategic Positioning

11.5.4    Product Portfolio

11.6    Lonza Group Ltd

11.6.1    Company Overview

11.6.2    Financial Analysis

11.6.3    Strategic Positioning

11.6.4    Product Portfolio

11.7    ChromaTan Inc.

11.7.1    Company Overview

11.7.2    Financial Analysis

11.7.3    Strategic Positioning

11.7.4    Product Portfolio

11.8    Repligen Corporation

11.8.1    Company Overview

11.8.2    Financial Analysis

11.8.3    Strategic Positioning

11.8.4    Product Portfolio

11.9 3M Purification

11.9.1    Company Overview

11.9.2    Financial Analysis

11.9.3    Strategic Positioning

          11.9.4    Product Portfolio

11.10 Meissner Filtration Products Inc.

11.10.1    Company Overview

11.10.2    Financial Analysis

11.10.3    Strategic Positioning

          11.10.4    Product Portfolio

11.11 DrM, Dr. Mueller AG

11.11.1    Company Overview

11.11.2    Financial Analysis

11.11.3    Strategic Positioning

          11.11.4    Product Portfolio

11.12 Other Companies

11.12.1    Company Overview

11.12.2    Financial Analysis

11.12.3    Strategic Positioning

          11.12.4    Product Portfolio

List of Tables

1 Technological Advancements In Adeno-associated virus vectors (AAVs) downstream processing Market

2 Global Adeno-associated virus vectors (AAVs) downstream processing Market: Key Market Drivers

3 Global Adeno-associated virus vectors (AAVs) downstream processing Market: Key Market Challenges

4 Global Adeno-associated virus vectors (AAVs) downstream processing Market: Key Market Opportunities

5 Global Adeno-associated virus vectors (AAVs) downstream processing Market: Key Market Restraints

6 Global Adeno-associated virus vectors (AAVs) downstream processing Market Estimates & Forecast Analysis, 2022-2028 (USD Billion)

7 Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

8 Filtration Solutions: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

9 Chromatography: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

10 Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Workflows, 2022-2028 (USD Billion)

11 Purification: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

12 Fill Finish: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

13 Polishing: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

14 Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

15 Single-use: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

16 Multi-use: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

17 Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

18 Cell & Gene Therapy Development: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

19 Vaccine Development: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

20 Global Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

21 Research Institutes: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

22 Pharmaceutical and Biopharmaceutical Companies: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

23 Regional Analysis: Global Adeno-associated virus vectors (AAVs) downstream processing Market, By Region, 2022-2028 (USD Billion)

24 North America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

25 North America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

26 North America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application , 2022-2028 (USD Billion)

27 North America: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

28 North America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Country, 2022-2028 (USD Billion)

29 U.S: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

30 U.S: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

31 U.S: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

32 U.S: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

33 Canada: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

34 Canada: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

35 Canada: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

36 Canada: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

37 Mexico: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

38 Mexico: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

39 Mexico: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

40 Mexico: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

41 Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

42 Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

43 Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

44 Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

45 Germany: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

46 Germany: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

47 Germany: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

48 Germany: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

49 UK: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

50 UK: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

51 UK: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

52 UK: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

53 France: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

54 France: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

55 France: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

56 France: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

57 Italy: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

58 Italy: Adeno-associated virus vectors (AAVs) downstream processing Market, By T Product Type Ype, 2022-2028 (USD Billion)

59 Italy: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

60 ltaly: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

61 Spain: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

62 Spain: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

63 Spain: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

64 Spain: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

65 Rest Of Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

66 Rest Of Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

67 Rest Of Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

68 Rest of Europe: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

69 Asia Pacific: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

70 Asia Pacific: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

71 Asia Pacific: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

72 Asia Pacific: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

73 Asia Pacific: Adeno-associated virus vectors (AAVs) downstream processing Market, By Country, 2022-2028 (USD Billion)

74 China: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

75 China: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

76 China: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

77 China: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

78 India: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

79 India: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

80 India: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

81 India: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

82 Japan: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

83 Japan: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

84 Japan: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

85 Japan: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

86 South Korea: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

87 South Korea: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

88 South Korea: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

89 South Korea: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

90 Middle East & Africa: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

91 Middle East & Africa: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

92 Middle East & Africa: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

93 Middle East & Africa: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

94 Middle East & Africa: Adeno-associated virus vectors (AAVs) downstream processing Market, By Country, 2022-2028 (USD Billion)

95 Saudi Arabia: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

96 Saudi Arabia: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

97 Saudi Arabia: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

98 Saudi Arabia: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

99 UAE: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

100 UAE: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

101 UAE: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

102 UAE: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

103 Central & South America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

104 Central & South America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

105 Central & South America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

106 Central & South America: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

107 Central & South America: Adeno-associated virus vectors (AAVs) downstream processing Market, By Country, 2022-2028 (USD Billion)

108 Brazil: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product, 2022-2028 (USD Billion)

109 Brazil: Adeno-associated virus vectors (AAVs) downstream processing Market, By Product Type, 2022-2028 (USD Billion)

110 Brazil: Adeno-associated virus vectors (AAVs) downstream processing Market, By Application, 2022-2028 (USD Billion)

111 Brazil: Adeno-associated virus vectors (AAVs) downstream processing Market, By End-User, 2022-2028 (USD Billion)

112 Sartorius: Products Offered

113 Merck KGaA: Products Offered

114 Thermo Fisher Scientific Inc.: Products Offered

115 Danaher Corporation: Products Offered

116 Lonza Group Ltd: Products Offered

117 ChromaTan Inc.: Products Offered

118 Repligen Corporation Inc: Products Offered

119 3M Purification: Products Offered

120 Meissner Filtration Products Inc.: Products Offered

121 DrM, Dr. Mueller AG: Products Offered

122 Other Companies: Products Offered

List of Figures

1. Global Adeno-associated virus vectors (AAVs) downstream processing Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global Adeno-associated virus vectors (AAVs) downstream processing Market: Penetration & Growth Prospect Mapping

7. Global Adeno-associated virus vectors (AAVs) downstream processing Market: Value Chain Analysis

8. Global Adeno-associated virus vectors (AAVs) downstream processing Market Drivers

9. Global Adeno-associated virus vectors (AAVs) downstream processing Market Restraints

10. Global Adeno-associated virus vectors (AAVs) downstream processing Market Opportunities

11. Global Adeno-associated virus vectors (AAVs) downstream processing Market Challenges

12. Key Adeno-associated virus vectors (AAVs) downstream processing Market Manufacturer Analysis

13. Global Adeno-associated virus vectors (AAVs) downstream processing Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Sartorius: Company Snapshot

16. Sartorius: SWOT Analysis

17. Merck KGaA: Company Snapshot

18. Merck KGaA: SWOT Analysis

19. Thermo Fisher Scientific Inc.: Company Snapshot

20. Thermo Fisher Scientific Inc.: SWOT Analysis

21. Danaher Corporation: Company Snapshot

22. Danaher Corporation: SWOT Analysis

23. Lonza Group Ltd: Company Snapshot

24. Lonza Group Ltd: SWOT Analysis

25. ChromaTan Inc.: Company Snapshot

26. ChromaTan Inc.: SWOT Analysis

27. Repligen Corporation Inc: Company Snapshot

28. Repligen Corporation Inc: SWOT Analysis

29. 3M Purification: Company Snapshot

30. 3M Purification: SWOT Analysis

31. Meissner Filtration Products Inc.: Company Snapshot

32. Meissner Filtration Products Inc.: SWOT Analysis

33. DrM, Dr. Mueller AG: Company Snapshot

34. DrM, Dr. Mueller AG: SWOT Analysis

35. Other Companies: Company Snapshot

36. Other Companies: SWOT Analysis

The Global Adeno-associated Virus Vectors (AAVs) Downstream Processing Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Adeno-associated Virus Vectors (AAVs) Downstream Processing Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The adeno-associated virus vectors (AAVs) downstream processing market is projected to grow at a CAGR of 15.3% from 2022 to 2028.
The paramount competitors covered in the adeno-associated virus vectors (AAVs) downstream processing market report are Sartorius, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group Ltd, ChromaTan Inc., Repligen Corporation, 3M Purification, Meissner Filtration Products, Inc., and DrM, Dr. Mueller AG among others
Due to substantial growth and interest in various fields of research in the medical sector, the global market for adeno-associated virus vectors (AAVs) downstream processing market has seen an increased market share. Due to the pandemic, the growth is accelerated for downstream processing techniques as it is used for the development of COVID-19 vaccines.
Adeno-associated virus vectors (AAVs) downstream processing market offers space for the modification of cells, and standardization of cells which can be utilized for cancer treatments, diabetes trials, and cardiovascular diseases. Many stem cell treatments are costly, but due to their widespread use in clinical research and disease treatment, the global adeno-associated virus vectors (AAVs) downstream processing market is expected to grow during the forecast period.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius